Longfellow Real Estate Partners has offloaded its maiden New York City project, the Hatch Life Sciences Building in Long Island City, Queens, for $86.9 million. The sale marks a retreat from the developer's initial ambitions for the asset at 43-10 23 Street.
Pearl Realty Management, represented by Jack Guttman, acquired the property. The deal closed at a discount relative to development costs and market expectations when the project launched, underscoring softer demand for life sciences real estate in outer boroughs despite earlier optimism around the sector.
The Hatch Building sits in Long Island City's emerging life sciences cluster, an area where developers positioned themselves to capture demand from biotech firms seeking alternatives to Manhattan's expensive lab space. The project featured modern laboratory facilities and amenities designed to attract life sciences tenants. However, the sector has cooled considerably since the pandemic boom, with rising interest rates and tightened venture capital funding pressuring demand.
For Longfellow, the sale reflects a strategic pivot. The firm, known for life sciences development, appears willing to accept losses on its NYC entry to redeploy capital elsewhere or exit the market entirely. Selling below expectations sends a signal to other developers holding speculative life sciences assets, particularly in secondary markets like Queens and Brooklyn.
For buyers like Pearl Realty Management, the discounted price presents an acquisition opportunity. Guttman and Pearl may operate the building as a long-term income asset or attempt repositioning if life sciences demand stabilizes. The sub-$87 million valuation also leaves room for value-add strategies if market conditions improve.
For landlords and property owners in LIC, the sale reflects softening institutional demand for specialized real estate. For tenants, a new ownership structure could mean different management priorities, potentially affecting lease terms and renewal negotiations. The deal underscores how Queens